BCDA BioCardia, Inc.
$1.08▼ -1.82%
Healthcare
Other
After hours
$1.06▼ -1.69%
Sep 11, 4:51 PM ET
Volume 137.0K
Avg Volume (10D) 115.9K
Key Metrics & Fundamentals
Market Cap
$16.35M
P/E Ratio
–
Div Yield
–%
52W Range
0.75 - 2.27
% vs 50 MA
10.93%
% vs 200 MA
-4.71%
RSI-14
54.6
MACD Histogram
-0.0100
Beta (1Y vs SPY)
0.59
Free Cash Flow
-$1.66M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$2.26M
COGS
–
Operating Exp
$2.27M
Operating Income
-$2.27M
EBIT
-$2.27M
Pretax Income
-$2.26M
Net Income
-$2.26M
EPS (Diluted)
-0.21
Price & Volume History
Loading chart…
Recent News
BioCardia to Present CardiAMP Regulatory and Corporate Progress at H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire · Sep 10, 2026 12:30 PM
BioCardia Announces FDA Confirms Helix Transendocardial Delivery Catheter Meeting Minutes Supporting Follow-On De Novo Pre-Submission for Approval
GlobeNewswire · Aug 24, 2026 12:30 PM
BioCardia (BCDA) Q2 2026 Earnings Call Transcript
Motley Fool · Aug 19, 2026 10:28 PM
BioCardia Inc (BCDA) (Q2 2026) Earnings Call Highlights: Regulatory Wins in Japan and US ...
GuruFocus.com · Aug 13, 2026 5:04 AM
BioCardia, Inc. Q2 2026 Earnings Call Summary
Moby · Aug 13, 2026 1:00 AM
BioCardia Reports Second Quarter 2026 Business Highlights and Financial Results
GlobeNewswire · Aug 12, 2026 8:05 PM
BioCardia to Host Q2 2026 Financial Results and Corporate Update Conference Call on August 12, 2026
GlobeNewswire · Aug 5, 2026 7:16 PM
Congestive Heart Failure Market to Register Immense Growth at a CAGR of 8% During the Forecast Period (2026-2036) | DelveInsight
PR Newswire · Jul 28, 2026 2:32 PM
New Strong Sell Stocks for July 14th
Zacks · Jul 14, 2026 11:16 AM
BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities
GlobeNewswire · Jun 18, 2026 12:00 PM
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See BCDA's money flow as a full page
Social Sentiment
No Reddit posts found for BCDA.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.